Metformin Prevents Peritoneal Dissemination <i>via</i> Immune-suppressive Cells in the Tumor Microenvironment

Abstract

Our findings demonstrate the action of metformin on both intraperitoneal tumors and immune-suppressive cells and might contribute to the development of immunotherapy against peritoneal dissemination.